UNITAID, which buys three fourth of its total quantity medicines from India for its global programmes, is wooing India to become a contributing member and enter its board to make a difference for the developing world.

The search for a new tuberculosis drug after many decades and first time through a unique model of open drug discovery programme may finally bear fruits in near future, with India all set for the launch of the phase II clinical trial of the drug candidate.